Development of the First Ultra-Potent “Capsaicinoid” Agonist at Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels and Its Therapeutic Potential-Reference-Cited by-同舟云学术

Development of the First Ultra-Potent “Capsaicinoid” Agonist at Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels and Its Therapeutic Potential

Published:2004-09-08 Issue:2 Volume:312 Page:561-570
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Appendino Giovanni,De Petrocellis Luciano,Trevisani Marcello,Minassi Alberto,Daddario Nives,Moriello Aniello Schiano,Gazzieri David,Ligresti Alessia,Campi Barbara,Fontana Gabriele,Pinna Christian,Geppetti Pierangelo,Di Marzo Vincenzo

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists

2. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin

3. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1

4. Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of ion channels therapeutics in the treatment of pain;Arabian Journal of Chemistry;2023-10

2. Highly Efficient Real-Time TRPV1 Screening Methodology for Effective Drug Candidates;ACS Omega;2022-10-04

3. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels;British Journal of Pharmacology;2021-09-16

4. Natural Products and some semi-synthetic analogues as potential TRPV1 Ligands for attenuating Neuropathic pain;Current Pharmaceutical Biotechnology;2021-07-19

5. Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy;Expert Opinion on Therapeutic Targets;2021-07-03